LFG
BIOL

Larson Financial Group’s Biolase, Inc. BIOL Stock Holding History

Larson Financial Group’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-7
Closed -$13K – 966
2021
Q2 		$13K Sell
7
-1
-13% -$1.86K ﹤0.01% 515
2021
Q1 		$17K Sell
8
-14
-64% -$34.4K 0.01% 446
2020
Q4 		$23K Buy
+22
New +$16.8K 0.01% 351

Other funds holding BIOL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Larson Financial Group's BIOL Position: Q3 2021 in Review

Larson Financial Group sold out of Biolase, Inc. (BIOL) in Q3 2021, closing a stake of 7 shares — an estimated $13K sold.

Larson Financial Group first reported a position in BIOL in Q4 2020 and held it in 3 quarters. The position peaked at $23K in Q4 2020. 38 funds tracked by Wall St. Rank hold BIOL as of Q3 2021.

  • Larson Financial Group reported no remaining Biolase, Inc. position as of Q3 2021 after selling out during the quarter.
  • Larson Financial Group sold 7 Biolase, Inc. shares in Q3 2021, an estimated $13K.
  • Larson Financial Group first reported a position in Biolase, Inc. in Q4 2020 and held it in 3 quarters.
  • Larson Financial Group's Biolase, Inc. position peaked at $23K in Q4 2020.
  • 38 funds tracked by Wall St. Rank held Biolase, Inc. as of Q3 2021.

Based on Larson Financial Group's 13F filing for Q3 2021, filed 4 Nov 2021.